Hudson Bay Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,600
Closed -$1.05M 1671
2025
Q2
$1.05M Buy
+2,600
New +$1.09M ﹤0.01% 950
2017
Q2
Sell
-5,000
Closed -$768K 786
2017
Q1
$768K Sell
5,000
-115,300
-96% -$17.6M 0.01% 661
2016
Q4
$17M Buy
+120,300
New +$17.7M 0.35% 54
2016
Q3
Sell
-50,000
Closed -$7.39M 506
2016
Q2
$7.39M Buy
+50,000
New +$7.38M 0.23% 75

Other funds holding TMO

Hudson Bay Capital Management's TMO Position: Q4 2025 in Review

Hudson Bay Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 775 shares — an estimated $376K sold.

Hudson Bay Capital Management first reported a position in TMO in Q3 2013 and held it in 19 quarters. The position peaked at $43.3M in Q1 2018. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Hudson Bay Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 775 Thermo Fisher Scientific shares in Q4 2025, an estimated $376K.
  • Hudson Bay Capital Management first reported a position in Thermo Fisher Scientific in Q3 2013 and held it in 19 quarters.
  • Hudson Bay Capital Management's Thermo Fisher Scientific position peaked at $43.3M in Q1 2018.
  • 2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Hudson Bay Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.